[ Price : $8.95]
Public Citizen says that some Roche claims for Tamiflu havent been proven and healthy adults should not use the drug for routine f...[ Price : $8.95]
Hemispherx Biopharma and its manufacturing subcontractor submit comprehensive new data to FDAs Seattle, WA regional office to addr...[ Price : $8.95]
FDA releases 11/09 labeling changes for 44 drugs, including boxed warnings for the TNF-blocker class of drugs.[ Price : $8.95]
Former National Restaurant Association chief administrative officer Molly Varney Muldoon joins FDA as commissioner Margaret Hambur...[ Price : $8.95]
FDA gives final approval to Aurobindo Pharma for cetirizine hydrochloride syrup 1mg/mL, a generic copy of McNeil Consumer Healthca...[ Price : $8.95]
FDAs Oncologic Drugs Advisory Committee recommends 9-8 that FDA approve Photocures Hexvix bladder cancer imaging drug.[ Price : $8.95]
Keryx Biopharmaceuticals opens a Phase 3 trial of perifosine in relapsed and refractory multiple myeloma patients.[ Price : $8.95]
FDA clears an Agendia 510(k) for the MammaPrint breast cancer recurrence test that broadens its use to women of all ages.